A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
about
A Rational Approach for the Identification of Non-Hydroxamate HDAC6-Selective InhibitorsIdentification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistanceThe Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with DoxorubicinRhoB upregulation leads to either apoptosis or cytostasis through differential target selection.AKT activation controls cell survival in response to HDAC6 inhibition.Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.Ibrutinib-A double-edge sword in cancer and autoimmune disorders.Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies.HDACs and HDAC Inhibitors in Cancer Development and Therapy.Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells.Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.TDP-43/HDAC6 axis promoted tumor progression and regulated nutrient deprivation-induced autophagy in glioblastoma.Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer.Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137).Selective Inhibition of Histone Deacetylation in Melanoma Increases Targeted Gene Delivery by a Bacteriophage Viral Vector.Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitors.
P2860
Q28830529-4E274E5E-4EEE-4582-83FC-8D0D150AA38EQ33622943-08FB212B-55F7-45BF-A856-8ED74BFE3E9DQ35000329-E8DC74AC-3BD9-4676-BE11-BAC5B1DE7D2AQ35890561-B9A96FFB-1985-42D8-BABE-8D93CE598756Q36027160-3DD1EAB4-34A0-4494-BD4A-703833B6726CQ37412534-7A8E3882-7BB1-4E4E-B2C0-4F8651D435FEQ38240733-8BCBB53C-024A-4FBA-8CF0-9563A6ADBB08Q38585329-11132D17-EE62-436E-9F70-573C7061086EQ38828275-E573C7E6-606E-428C-BD58-DDE2839C4149Q38947405-92AD0EEC-9EFD-4D3E-BA74-687C714293E5Q39016475-4D7FAF7B-1639-47EC-A949-AE068D6992D5Q39640572-1BC76D19-5551-4EED-8526-67A4D7CAF76AQ41345579-CF0D5616-41A0-4D55-A737-13589F3F9AAEQ41382946-B0363354-FFFC-4EFB-856A-AB3E888C1548Q51188342-7F0717EA-ED05-4FA8-9430-B744E9188920Q52717013-BC450444-1BF0-4D16-823E-B77FF269E7EFQ55280808-847CAF82-9D3B-4CE0-87FA-DD4F0DE0035D
P2860
A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@ast
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@en
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@en-gb
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@nl
type
label
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@ast
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@en
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@en-gb
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@nl
prefLabel
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@ast
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@en
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@en-gb
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@nl
P2093
P2860
P3181
P356
P1476
A novel small molecule hydroxa ...... AC6 activity and tumour growth
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/BJC.2012.576
P407
P577
2013-02-05T00:00:00Z
P5875
P6179
1045637490